FDA’s START and CoGenT pilot programmes: Streamlining rare disease drug approvals
FDA’s START and CoGenT pilot programmes: Streamlining rare disease drug approvals
Published: 01/20/2025
Published: 01/20/2025
FDA’s START and CoGenT pilot programmes: Streamlining rare disease drug approvals